46 related articles for article (PubMed ID: 26226849)
21. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
22. [Spice drugs: cannabinoids as a new designer drugs].
Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
24. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
25. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.
Ogata J; Uchiyama N; Kikura-Hanajiri R; Goda Y
Forensic Sci Int; 2013 Apr; 227(1-3):33-41. PubMed ID: 23092848
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Synthetic Cannabinoids in Botanical Material: A Review of Analytical Methods and Findings.
Presley BC; Jansen-Varnum SA; Logan BK
Forensic Sci Rev; 2013 Mar; 25(1-2):27-46. PubMed ID: 26226849
[TBL] [Abstract][Full Text] [Related]
27. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
Cottencin O; Rolland B; Karila L
Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
[TBL] [Abstract][Full Text] [Related]
28. Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review.
de Oliveira MC; Vides MC; Lassi DLS; Torales J; Ventriglio A; Bombana HS; Leyton V; Périco CA; Negrão AB; Malbergier A; Castaldelli-Maia JM
Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508922
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.
Gurney SM; Scott KS; Kacinko SL; Presley BC; Logan BK
Forensic Sci Rev; 2014 Jan; 26(1):53-78. PubMed ID: 26226970
[TBL] [Abstract][Full Text] [Related]
30. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.
Miliano C; Serpelloni G; Rimondo C; Mereu M; Marti M; De Luca MA
Front Neurosci; 2016; 10():153. PubMed ID: 27147945
[TBL] [Abstract][Full Text] [Related]
31. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
Brents LK; Prather PL
Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
Funada M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
[TBL] [Abstract][Full Text] [Related]
33. Synthetic cannabinoids: analysis and metabolites.
Elsohly MA; Gul W; Wanas AS; Radwan MM
Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
[TBL] [Abstract][Full Text] [Related]
34. ["Spice"--synthetic cannabinoids with dangerous effects].
Personne M; Westerbergh J; Hammer-Pettersen L
Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
[TBL] [Abstract][Full Text] [Related]
35. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
[TBL] [Abstract][Full Text] [Related]
36. [The illegal synthetic cannabinoid drug market in Israel - evolution and new challenges].
Shapira B; Poperno A; Berkovitz R
Harefuah; 2016 Sep; 155(9):526-530. PubMed ID: 28530077
[TBL] [Abstract][Full Text] [Related]
37. Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.
Castellanos D; Gralnik LM
World J Clin Pediatr; 2016 Feb; 5(1):16-24. PubMed ID: 26862498
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacological properties of law-evading chemical substances].
Funada M
Nihon Rinsho; 2015 Sep; 73(9):1487-90. PubMed ID: 26394508
[TBL] [Abstract][Full Text] [Related]
39. Review of analytical methods for identification and quantification of cannabis products.
Vollner L; Bieniek D; Korte F
Regul Toxicol Pharmacol; 1986 Dec; 6(4):348-58. PubMed ID: 3027768
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
